Notably, S100a1 loss delayed LLC tumor growth and prolonged survival in immune-competent C57BL/6J mice (Fig. 2c), suggesting that T-cell-mediated immunity contributed to the antitumor activity of tumor-intrinsic S100a1 loss. The gene discussed is S100A1; the disease is neoplasm.